雅天妮集團(00789.HK)預計年度溢利大幅下跌65%
格隆匯6月18日丨雅天妮集團(00789.HK)宣佈,公司預計截至2020年3月31日止年度取得的溢利將同比大幅下跌約65%。減少乃主要由於集團綜合時尚配飾平台業務產生的收益主要因新型冠狀病毒(COVID-19)疫情於2020年1月爆發而減少約16%;集團的毛利率由上年度約31.7%下跌至本年度約24.4%,乃主要由於產品升級及包裝改進以致產品的單位成本上升,但並無向客户收取更高價格;及並無上個財政年度確認的出售附屬公司收益約800萬港元。
展望將來,公司將繼續密切監察市場狀況及加強成本控制,以應對營商環境波動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.